Sector Monte Rosa Therapeutics, Inc.

Aandelen

GLUE

US61225M1027

Biotechnologie & Medisch Onderzoek

Beurs gesloten - 22:00:00 21-08-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
14,30 USD -3,25% Intraday-grafiek van Monte Rosa Therapeutics, Inc. -7,74% -8,80%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-3,25%-7,74%-37,91%-23,98%-8,80%+196,68%+123,79%-61,29% - 1,22 mld.
-0,52%+3,88%+7,37%+19,72%+9,41%+2,72%+23,23%-23,49%+211,82% 51,61 mld.
-1,07%+2,82%+10,97%+38,20%+162,98%+465,96%+570,70%+705,93% - 44,89 mld.
+1,47%+9,79%+25,32%+54,75%+15,27%+35,92%+20,21%+2,14%+241,82% 42,77 mld.
+1,44%+7,77%+14,60%+20,70%+23,26%+19,38%+84,65%+37,00%+1.173,27% 42,58 mld.
-0,93%-4,33%+11,67%+1,62%+11,56%+16,18%+55,82%-17,64%+149,91% 31,82 mld.
+1,32%+7,30%+2,46%+43,43%+10,52%+33,89%+148,53%+246,25%+2.026,58% 17,33 mld.
-0,60%+1,93%+0,25%+2,53% - - - - - 16,63 mld.
+0,38%+4,46%+10,12%+15,62%+17,18%+9,56%+30,62%-38,21%+98,59% 14,76 mld.
+1,28%+5,41%+28,74%+84,15%+47,98%+82,40%+46,13%-30,68%+253,31% 14,09 mld.
-1,17%+5,57%+1,12%+47,48%-5,48%-2,05%-31,86%-29,70%+123,88% 13,29 mld.
+9,06%+39,52%+57,99%+57,41%+23,10%-9,72% - - - 13,12 mld.
-5,74%-2,32%+23,03%+85,04%+68,77%+59,40%+79,43%-40,22% - 12,06 mld.
+0,06%-0,11%+0,77%+50,01%+22,97%+26,68%-8,08%-39,72%+171,29% 11,34 mld.
-2,80%-6,56%-12,28%-14,03%-17,82%+51,30%+491,10%+242,39%+2.386,18% 11,12 mld.
+3,12%+2,49%+16,61%+9,42%+27,55%+670,68%+1.582,06%+26,39% - 10,5 mld.
0,00%+0,15%+0,36%+66,03%+78,52%+252,10%+448,88% - - 10,16 mld.
+2,41%-0,50%+13,95%+55,58%+76,69%+168,48%+657,58%+211,19%+1.244,25% 9,99 mld.
-1,40%+2,05%+8,53%+51,86%+53,96%+171,66%+490,15%+116,60% - 9,96 mld.
+1,67%+4,37%+6,93%-20,94%-24,48%+39,94%+50,40%+53,06%+77,22% 9,93 mld.
Gemiddelde -0,31%+4,04%+9,53%+32,23%+31,22%+120,59%+270,19%+80,00%+679,84% 19,46 mld.
Gewogen gemiddelde per kap. -0,07%+4,92%+12,59%+32,49%+38,07%+109,77%+211,21%+115,16%+589,22%
  1. Beurs
  2. Aandelen
  3. Koers GLUE
  4. Sector Monte Rosa Therapeutics, Inc.